AKOYA BIOSCIENCES, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.835 USD | -0.65% |
|
0.00% | -21.93% |
Presenter SpeechUduak Thomas (Attendees)Hello, everyone, to the first of what will be a 2-part...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
Calendar
2024-05-12
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
3.86
USD
Average target price
9
USD
Spread / Average Target
+133.16%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -21.93% | 191M | |
| +7.76% | 220B | |
| +5.92% | 183B | |
| +9.98% | 133B | |
| +25.45% | 107B | |
| -1.86% | 63.05B | |
| +12.41% | 51.74B | |
| +3.96% | 50.47B | |
| -0.56% | 40.91B | |
| +24.17% | 31.91B |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Transcript : Akoya Biosciences, Inc. - Special Call
